NM

R New Jersey General Assembly · District 21 · Former member

Asm. Nancy Muñoz

Contact Email Phone Official site ↗

Compare

Total votes

5,751

all sessions

Attendance

94%

278 missed

Near the chamber average

With party

96%

of cast votes

Lower than 82% of chamber peers

Bipartisan score

3%

crosses aisle rarely

Higher than 82% of chamber peers

Voting record

Yea

4,550

voted in favor

Nay

743

voted against

Absent

278

missed votes

Total cast

5,751

across all sessions

Crossed party

197

votes against own party

This page

5,751

matching current filters

Bill

Description

Vote

Result

Tally

Date

A 1930

Allows certain State agencies to sell Internet advertisements on agencies' websites as pilot program.

Yea

Passed

69–0

Oct 20, 2016

A 2805

Requires DMVA to develop online historic tour identifying locations of war battles and places of significance to war efforts in State.

Yea

Passed

66–0

Oct 20, 2016

A 3367

Allows gross income tax deduction for 50% of contributions of $100 or more to domestic violence shelters.

Yea

Passed

6–0

Oct 13, 2016

A 2685

Establishes Study Commission on Gender Pay Discrimination.

Yea

Passed

6–0

Oct 13, 2016

A 4125

Establishes mandatory training program for human resources officers of public employers on handling and responding to reports of domestic violence.

Yea

Passed

6–0

Oct 13, 2016

A 843

Requires counseling for certain domestic violence offenders.

Yea

Passed

6–0

Oct 13, 2016

A 4124

Requires public employers to implement certain policies for handling and responding to reports of domestic violence.

Yea

Passed

6–0

Oct 13, 2016

A 10

Revises "New Jersey Transportation Trust Fund Authority Act"; establishes State Transportation Infrastructure Bank within NJ Environmental Infrastructure Trust; renames NJ Environmental Infrastructure Trust.

Other

Passed

44–24

Oct 7, 2016

A 12

Adjusts certain State taxes to support strengthened investments in public and private assets in this State.*

Other

Passed

44–24

Oct 7, 2016

S 2024

Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.

Yea

Passed

10–0

Oct 6, 2016